[1]
Elmiladi, S.A. et al. 2020. SGLT2 inhibitor: metabolic effect on Libyan patients with T2DM at National Diabetes Center in Tripoli. Libyan Journal of Medical Research. 14, 1 (Jun. 2020), 25–37. DOI:https://doi.org/10.54361/ljmr.v14i1.03.